Blocking agents

Size: 100 ug Target Name(s): SARS-CoV-2 S1 RBD Species Detected: Virus Specificity: This antibody was selected for its ability to bind to the virus SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD) from the disease COVID-19.

Whole IgG antibodies are isolated as intact molecules from antisera by immunoaffinity chromatography. They have an Fc portion and two antigen binding Fab portions joined together by disulfide bonds and therefore they are divalent.

Immunogen: Peptide sequence specific to Zaire Ebola virus (ZEBOV) L-Polymerase protein. Description: Affinity purified rabbit polyclonal antibody reactive to Zaire Ebola virus L-Polymerase.

Immunogen: Peptide sequence specific to Ebola virus (EBOV) Nucleocapsid Protein (NP). Description: Affinity purified rabbit polyclonal antibody reactive to EBOV NP.

ANTI-ERMP1

Argatroban

Miptenalimab (anti-LAG3) is an anti-human LAG-3 antibody (KD: 88.6 nM for h LAG-3).

Miptenalimab (anti-LAG3) is an anti-human LAG-3 antibody (KD: 88.6 nM for h LAG-3).

Miptenalimab (anti-LAG3) is an anti-human LAG-3 antibody (KD: 88.6 nM for h LAG-3).

Miptenalimab (anti-LAG3) is an anti-human LAG-3 antibody (KD: 88.6 nM for h LAG-3).

PRIVACY SCREEN

General description Rabbit polyclonal antibody supplied as undiluted serum. Recognizes the ~115 kDa endogenous as well as recombinant IDE protein.